Inhibition of the mitochondrial nicotinamide nucleotide transhydrogenase by dicyclohexylcarbodiimide and diethylpyrocarbonate.
The mitochondrial nicotinamide nucleotide transhydrogenase enzyme (EC 1.6.1.1) is inhibited by treatment with dicyclohexylcarbodiimide or diethylpyrocarbonate. Both inhibitions are pseudo first order with respect to incubation time, and both reaction orders with respect to inhibitor concentration are close to unit, indicating that in each case inhibition results from the binding of one inhibitor molecule per active unit of the transhydrogenase enzyme. In the presence of either inhibitor, both the energy-linked and the nonenergy-linked transhydrogenation reactions are inhibited at about the same rate. The water-soluble carbodiimide, N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide, showed no inhibition, however, NAD(H) and reduced or oxidized 3-acetylpyridine adenine dinucleotide protected the enzyme against inhibition by dicyclohexylcarbodiimide, while NADP (but not NADPH) appeared to increase the rate of inhibition. Substrates did not protect the enzyme against inhibition by diethylpyrocarbonate. [14C]dicyclohexylcarbodiimide labeled the transhydrogenase enzyme in submitochondrial particles. Treatment of labeled particles with trypsin resulted in fragmentation of the transhydrogenase enzyme and loss of a labeled polypeptide of Mr = approximately 100,000 as determined by polyacrylamide gel electrophoresis.[1]References
- Inhibition of the mitochondrial nicotinamide nucleotide transhydrogenase by dicyclohexylcarbodiimide and diethylpyrocarbonate. Phelps, D.C., Hatefi, Y. J. Biol. Chem. (1981) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
